Cargando…

Simulating the effect of evaluation unit size on eligibility to stop mass drug administration for lymphatic filariasis in Haiti

BACKGROUND: The Transmission Assessment Survey (TAS) is a decision-making tool to determine when transmission of lymphatic filariasis is presumed to have reached a level low enough that it cannot be sustained even in the absence of mass drug administration. The survey is applied over geographic area...

Descripción completa

Detalles Bibliográficos
Autores principales: Kostandova, Natalya, Desir, Luccene, Direny, Abdel, Knipes, Alaine, Lemoine, Jean Frantz, Fayette, Carl Renand, Kirby, Amy, Gass, Katherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827424/
https://www.ncbi.nlm.nih.gov/pubmed/35089925
http://dx.doi.org/10.1371/journal.pntd.0010150
_version_ 1784647624971780096
author Kostandova, Natalya
Desir, Luccene
Direny, Abdel
Knipes, Alaine
Lemoine, Jean Frantz
Fayette, Carl Renand
Kirby, Amy
Gass, Katherine
author_facet Kostandova, Natalya
Desir, Luccene
Direny, Abdel
Knipes, Alaine
Lemoine, Jean Frantz
Fayette, Carl Renand
Kirby, Amy
Gass, Katherine
author_sort Kostandova, Natalya
collection PubMed
description BACKGROUND: The Transmission Assessment Survey (TAS) is a decision-making tool to determine when transmission of lymphatic filariasis is presumed to have reached a level low enough that it cannot be sustained even in the absence of mass drug administration. The survey is applied over geographic areas, called evaluation units (EUs); existing World Health Organization guidelines limit EU size to a population of no more than 2 million people. METHODOLOGY/PRINCIPAL FINDINGS: In 2015, TASs were conducted in 14 small EUs in Haiti. Simulations, using the observed TAS results, were performed to understand the potential programmatic impact had Haiti chosen to form larger EUs. Nine “combination-EUs” were formed by grouping adjacent EUs, and bootstrapping was used to simulate the expected TAS results. When the combination-EUs were comprised of at least one “passing” and one “failing” EU, the majority of these combination-EU would pass the TAS 79% - 100% of the time. Even in the case when both component EUs had failed, the combination-EU was expected to “pass” 11% of the time. Simulations of mini-TAS, a strategy with smaller power and hence smaller sample size than TAS, resulted in more conservative “passing” and “failing” when implemented in original EUs. CONCLUSIONS/SIGNIFICANCE: Our results demonstrate the high potential for misclassification when the average prevalence of lymphatic filariasis in the combined areas differs with regards to the TAS threshold. Of particular concern is the risk of “passing” larger EUs that include focal areas where prevalence is high enough to be potentially self-sustaining. Our results reaffirm the approach that Haiti took in forming smaller EUs. Where baseline or monitoring data show a high or heterogeneous prevalence, programs should leverage alternative strategies like mini-TAS in smaller EUs, or consider gathering additional data through spot check sites to advise EU formation.
format Online
Article
Text
id pubmed-8827424
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-88274242022-02-10 Simulating the effect of evaluation unit size on eligibility to stop mass drug administration for lymphatic filariasis in Haiti Kostandova, Natalya Desir, Luccene Direny, Abdel Knipes, Alaine Lemoine, Jean Frantz Fayette, Carl Renand Kirby, Amy Gass, Katherine PLoS Negl Trop Dis Research Article BACKGROUND: The Transmission Assessment Survey (TAS) is a decision-making tool to determine when transmission of lymphatic filariasis is presumed to have reached a level low enough that it cannot be sustained even in the absence of mass drug administration. The survey is applied over geographic areas, called evaluation units (EUs); existing World Health Organization guidelines limit EU size to a population of no more than 2 million people. METHODOLOGY/PRINCIPAL FINDINGS: In 2015, TASs were conducted in 14 small EUs in Haiti. Simulations, using the observed TAS results, were performed to understand the potential programmatic impact had Haiti chosen to form larger EUs. Nine “combination-EUs” were formed by grouping adjacent EUs, and bootstrapping was used to simulate the expected TAS results. When the combination-EUs were comprised of at least one “passing” and one “failing” EU, the majority of these combination-EU would pass the TAS 79% - 100% of the time. Even in the case when both component EUs had failed, the combination-EU was expected to “pass” 11% of the time. Simulations of mini-TAS, a strategy with smaller power and hence smaller sample size than TAS, resulted in more conservative “passing” and “failing” when implemented in original EUs. CONCLUSIONS/SIGNIFICANCE: Our results demonstrate the high potential for misclassification when the average prevalence of lymphatic filariasis in the combined areas differs with regards to the TAS threshold. Of particular concern is the risk of “passing” larger EUs that include focal areas where prevalence is high enough to be potentially self-sustaining. Our results reaffirm the approach that Haiti took in forming smaller EUs. Where baseline or monitoring data show a high or heterogeneous prevalence, programs should leverage alternative strategies like mini-TAS in smaller EUs, or consider gathering additional data through spot check sites to advise EU formation. Public Library of Science 2022-01-28 /pmc/articles/PMC8827424/ /pubmed/35089925 http://dx.doi.org/10.1371/journal.pntd.0010150 Text en https://creativecommons.org/publicdomain/zero/1.0/This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication.
spellingShingle Research Article
Kostandova, Natalya
Desir, Luccene
Direny, Abdel
Knipes, Alaine
Lemoine, Jean Frantz
Fayette, Carl Renand
Kirby, Amy
Gass, Katherine
Simulating the effect of evaluation unit size on eligibility to stop mass drug administration for lymphatic filariasis in Haiti
title Simulating the effect of evaluation unit size on eligibility to stop mass drug administration for lymphatic filariasis in Haiti
title_full Simulating the effect of evaluation unit size on eligibility to stop mass drug administration for lymphatic filariasis in Haiti
title_fullStr Simulating the effect of evaluation unit size on eligibility to stop mass drug administration for lymphatic filariasis in Haiti
title_full_unstemmed Simulating the effect of evaluation unit size on eligibility to stop mass drug administration for lymphatic filariasis in Haiti
title_short Simulating the effect of evaluation unit size on eligibility to stop mass drug administration for lymphatic filariasis in Haiti
title_sort simulating the effect of evaluation unit size on eligibility to stop mass drug administration for lymphatic filariasis in haiti
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827424/
https://www.ncbi.nlm.nih.gov/pubmed/35089925
http://dx.doi.org/10.1371/journal.pntd.0010150
work_keys_str_mv AT kostandovanatalya simulatingtheeffectofevaluationunitsizeoneligibilitytostopmassdrugadministrationforlymphaticfilariasisinhaiti
AT desirluccene simulatingtheeffectofevaluationunitsizeoneligibilitytostopmassdrugadministrationforlymphaticfilariasisinhaiti
AT direnyabdel simulatingtheeffectofevaluationunitsizeoneligibilitytostopmassdrugadministrationforlymphaticfilariasisinhaiti
AT knipesalaine simulatingtheeffectofevaluationunitsizeoneligibilitytostopmassdrugadministrationforlymphaticfilariasisinhaiti
AT lemoinejeanfrantz simulatingtheeffectofevaluationunitsizeoneligibilitytostopmassdrugadministrationforlymphaticfilariasisinhaiti
AT fayettecarlrenand simulatingtheeffectofevaluationunitsizeoneligibilitytostopmassdrugadministrationforlymphaticfilariasisinhaiti
AT kirbyamy simulatingtheeffectofevaluationunitsizeoneligibilitytostopmassdrugadministrationforlymphaticfilariasisinhaiti
AT gasskatherine simulatingtheeffectofevaluationunitsizeoneligibilitytostopmassdrugadministrationforlymphaticfilariasisinhaiti